메뉴 건너뛰기




Volumn 169, Issue 4, 2013, Pages 784-793

A novel fluorophosphonate inhibitor of the biosynthesis of the endocannabinoid 2-arachidonoylglycerol with potential anti-obesity effects

Author keywords

2 arachidonoylglycerol; anti obesity effects; cannabinoid; diacylglycerol; inhibitor; serine lipase

Indexed keywords

2 ARACHIDONOYLGLYCEROL; ACYLGLYCEROL LIPASE; ANTIOBESITY AGENT; CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR; DIACYLGLYCEROL LIPASE ALPHA; DIACYLGLYCEROL LIPASE ALPHA INHIBITOR; FATTY ACID AMIDASE; FLUOROPHOSPHONIC ACID DERIVATIVE; IONOMYCIN; LIPOPROTEIN LIPASE; O 7458; O 7459; O 7460; UNCLASSIFIED DRUG;

EID: 84875911353     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/bph.12013     Document Type: Article
Times cited : (65)

References (31)
  • 1
    • 81355156238 scopus 로고    scopus 로고
    • Guide to receptors and channels (GRAC)
    • 5th edition
    • Alexander SPH, Mathie A, Peters JA, (2011). Guide to receptors and channels (GRAC), 5th edition. Br J Pharmacol 164 (Suppl. 1): S1-S324.
    • (2011) Br J Pharmacol , vol.164 , Issue.SUPPL. 1
    • Alexander, S.P.H.1    Mathie, A.2    Peters, J.A.3
  • 2
    • 79957551226 scopus 로고    scopus 로고
    • Supply and demand for endocannabinoids
    • Alger BE, Kim J, (2011). Supply and demand for endocannabinoids. Trends Neurosci 34: 304-315.
    • (2011) Trends Neurosci , vol.34 , pp. 304-315
    • Alger, B.E.1    Kim, J.2
  • 3
    • 0034189683 scopus 로고    scopus 로고
    • Orlistat in the treatment of obesity
    • Ballinger A, (2000). Orlistat in the treatment of obesity. Expert Opin Pharmacother 1: 841-847.
    • (2000) Expert Opin Pharmacother , vol.1 , pp. 841-847
    • Ballinger, A.1
  • 4
    • 10744229235 scopus 로고    scopus 로고
    • Cloning of the first sn-1-DAG lipases points to the spatial and temporal regulation of endocannabinoid signaling in the brain
    • Bisogno T, Howell F, Williams G, Minassi A, Cascio MG, Ligresti A, et al. (2003). Cloning of the first sn-1-DAG lipases points to the spatial and temporal regulation of endocannabinoid signaling in the brain. J Cell Biol 163: 463-468.
    • (2003) J Cell Biol , vol.163 , pp. 463-468
    • Bisogno, T.1    Howell, F.2    Williams, G.3    Minassi, A.4    Cascio, M.G.5    Ligresti, A.6
  • 5
  • 6
    • 67049136364 scopus 로고    scopus 로고
    • Synthesis and pharmacological activity of a potent inhibitor of the biosynthesis of the endocannabinoid 2-arachidonoylglycerol
    • Bisogno T, Burston JJ, Rai R, Allarà M, Saha B, Mahadevan A, et al. (2009a). Synthesis and pharmacological activity of a potent inhibitor of the biosynthesis of the endocannabinoid 2-arachidonoylglycerol. ChemMedChem 4: 946-950.
    • (2009) ChemMedChem , vol.4 , pp. 946-950
    • Bisogno, T.1    Burston, J.J.2    Rai, R.3    Allarà, M.4    Saha, B.5    Mahadevan, A.6
  • 7
    • 57649192489 scopus 로고    scopus 로고
    • Development of a potent inhibitor of 2-arachidonoylglycerol hydrolysis with antinociceptive activity in vivo
    • Bisogno T, Ortar G, Petrosino S, Morera E, Palazzo E, Nalli M, et al. (2009b). Development of a potent inhibitor of 2-arachidonoylglycerol hydrolysis with antinociceptive activity in vivo. Biochim Biophys Acta 1791: 53-60.
    • (2009) Biochim Biophys Acta , vol.1791 , pp. 53-60
    • Bisogno, T.1    Ortar, G.2    Petrosino, S.3    Morera, E.4    Palazzo, E.5    Nalli, M.6
  • 8
    • 0346725821 scopus 로고    scopus 로고
    • A structure-activity relationship study on N-arachidonoyl-amino acids as possible endogenous inhibitors of fatty acid amide hydrolase
    • Cascio MG, Minassi A, Ligresti A, Appendino G, Burstein S, Di Marzo V, (2004). A structure-activity relationship study on N-arachidonoyl-amino acids as possible endogenous inhibitors of fatty acid amide hydrolase. Biochem Biophys Res Commun 314: 192-196.
    • (2004) Biochem Biophys Res Commun , vol.314 , pp. 192-196
    • Cascio, M.G.1    Minassi, A.2    Ligresti, A.3    Appendino, G.4    Burstein, S.5    Di Marzo, V.6
  • 9
    • 79955396596 scopus 로고    scopus 로고
    • A potent and selective inhibitor of KIAA1363/AADACL1 that impairs prostate cancer pathogenesis
    • Chang JW, Nomura DK, Cravatt BF, (2011). A potent and selective inhibitor of KIAA1363/AADACL1 that impairs prostate cancer pathogenesis. Chem Biol 18: 476-484.
    • (2011) Chem Biol , vol.18 , pp. 476-484
    • Chang, J.W.1    Nomura, D.K.2    Cravatt, B.F.3
  • 10
    • 43249100162 scopus 로고    scopus 로고
    • Targeting the endocannabinoid system: To enhance or reduce?
    • Di Marzo V, (2008). Targeting the endocannabinoid system: to enhance or reduce? Nat Rev Drug Discov 7: 438-455.
    • (2008) Nat Rev Drug Discov , vol.7 , pp. 438-455
    • Di Marzo, V.1
  • 11
    • 70350347327 scopus 로고    scopus 로고
    • CB1 antagonists for obesity - What lessons have we learned from rimonabant?
    • Di Marzo V, Després JP, (2009). CB1 antagonists for obesity-what lessons have we learned from rimonabant? Nat Rev Endocrinol 5: 633-638.
    • (2009) Nat Rev Endocrinol , vol.5 , pp. 633-638
    • Di Marzo, V.1    Després, J.P.2
  • 12
    • 0030759362 scopus 로고    scopus 로고
    • Evidence that methyl arachidonyl fluorophosphonate is an irreversible cannabinoid receptor antagonist
    • Fernando SR, Pertwee RG, (1997). Evidence that methyl arachidonyl fluorophosphonate is an irreversible cannabinoid receptor antagonist. Br J Pharmacol 121: 1716-1720.
    • (1997) Br J Pharmacol , vol.121 , pp. 1716-1720
    • Fernando, S.R.1    Pertwee, R.G.2
  • 14
    • 77950647242 scopus 로고    scopus 로고
    • The cannabinoid 1-receptor silent antagonist O-2050 attenuates preference for high-fat diet and activated astrocytes in mice
    • Higuchi S, Irie K, Mishima S, Araki M, Ohji M, Shirakawa A, et al. (2010). The cannabinoid 1-receptor silent antagonist O-2050 attenuates preference for high-fat diet and activated astrocytes in mice. J Pharmacol Sci 112: 369-372.
    • (2010) J Pharmacol Sci , vol.112 , pp. 369-372
    • Higuchi, S.1    Irie, K.2    Mishima, S.3    Araki, M.4    Ohji, M.5    Shirakawa, A.6
  • 15
    • 78149411746 scopus 로고    scopus 로고
    • Increment of hypothalamic 2-arachidonoylglycerol induces the preference for a high-fat diet via activation of cannabinoid 1 receptors
    • Higuchi S, Ohji M, Araki M, Furuta R, Katsuki M, Yamaguchi R, et al. (2011). Increment of hypothalamic 2-arachidonoylglycerol induces the preference for a high-fat diet via activation of cannabinoid 1 receptors. Behav Brain Res 216: 477-480.
    • (2011) Behav Brain Res , vol.216 , pp. 477-480
    • Higuchi, S.1    Ohji, M.2    Araki, M.3    Furuta, R.4    Katsuki, M.5    Yamaguchi, R.6
  • 16
    • 84858990388 scopus 로고    scopus 로고
    • Cannabinoid-1 receptor (CB1R) blockers as medicines: Beyond obesity and cardiometabolic disorders to substance abuse/drug addiction with CB1R neutral antagonists
    • Janero DR, (2012). Cannabinoid-1 receptor (CB1R) blockers as medicines: beyond obesity and cardiometabolic disorders to substance abuse/drug addiction with CB1R neutral antagonists. Expert Opin Emerg Drugs 17: 17-29.
    • (2012) Expert Opin Emerg Drugs , vol.17 , pp. 17-29
    • Janero, D.R.1
  • 17
    • 84858067148 scopus 로고    scopus 로고
    • 2-arachidonoylglycerol signaling in forebrain regulates systemic energy metabolism
    • Jung KM, Clapper JR, Fu J, D'Agostino G, Guijarro A, Thongkham D, et al. (2012). 2-arachidonoylglycerol signaling in forebrain regulates systemic energy metabolism. Cell Metab 15: 299-310.
    • (2012) Cell Metab , vol.15 , pp. 299-310
    • Jung, K.M.1    Clapper, J.R.2    Fu, J.3    D'Agostino, G.4    Guijarro, A.5    Thongkham, D.6
  • 19
    • 57749087828 scopus 로고    scopus 로고
    • Selective blockade of 2-arachidonoylglycerol hydrolysis produces cannabinoid behavioral effects
    • Long JZ, Li W, Booker L, Burston JJ, Kinsey SG, Schlosburg JE, et al. (2009). Selective blockade of 2-arachidonoylglycerol hydrolysis produces cannabinoid behavioral effects. Nat Chem Biol 5: 37-44.
    • (2009) Nat Chem Biol , vol.5 , pp. 37-44
    • Long, J.Z.1    Li, W.2    Booker, L.3    Burston, J.J.4    Kinsey, S.G.5    Schlosburg, J.E.6
  • 20
    • 78650962985 scopus 로고    scopus 로고
    • Complementary synaptic distribution of enzymes responsible for synthesis and inactivation of the endocannabinoid 2-arachidonoylglycerol in the human hippocampus
    • Ludányi A, Hu SS, Yamazaki M, Tanimura A, Piomelli D, Watanabe M, et al. (2011). Complementary synaptic distribution of enzymes responsible for synthesis and inactivation of the endocannabinoid 2-arachidonoylglycerol in the human hippocampus. Neuroscience 174: 50-63.
    • (2011) Neuroscience , vol.174 , pp. 50-63
    • Ludányi, A.1    Hu, S.S.2    Yamazaki, M.3    Tanimura, A.4    Piomelli, D.5    Watanabe, M.6
  • 21
    • 77954331629 scopus 로고    scopus 로고
    • Guidelines for reporting experiments involving animals: The ARRIVE guidelines
    • McGrath J, Drummond G, Kilkenny C, Wainwright C, (2010). Guidelines for reporting experiments involving animals: the ARRIVE guidelines. Br J Pharmacol 160: 1573-1576.
    • (2010) Br J Pharmacol , vol.160 , pp. 1573-1576
    • McGrath, J.1    Drummond, G.2    Kilkenny, C.3    Wainwright, C.4
  • 22
    • 0036682222 scopus 로고    scopus 로고
    • The endogenous cannabinoid system controls extinction of aversive memories
    • Marsicano G, Wotjak CT, Azad SC, Bisogno T, Rammes G, Cascio MG, et al. (2002). The endogenous cannabinoid system controls extinction of aversive memories. Nature 418: 530-534.
    • (2002) Nature , vol.418 , pp. 530-534
    • Marsicano, G.1    Wotjak, C.T.2    Azad, S.C.3    Bisogno, T.4    Rammes, G.5    Cascio, M.G.6
  • 24
    • 50649106505 scopus 로고    scopus 로고
    • Cannabinoid-1 receptor antagonists reduce caloric intake by decreasing palatable diet selection in a novel dessert protocol in female rats
    • Mathes CM, Ferrara M, Rowland NE, (2008). Cannabinoid-1 receptor antagonists reduce caloric intake by decreasing palatable diet selection in a novel dessert protocol in female rats. Am J Physiol Regul Integr Comp Physiol 295: R67-R75.
    • (2008) Am J Physiol Regul Integr Comp Physiol , vol.295
    • Mathes, C.M.1    Ferrara, M.2    Rowland, N.E.3
  • 25
    • 0029012014 scopus 로고
    • Compton, identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors
    • Mechoulam R, Ben-Shabat S, Hanus L, Ligumsky M, Kaminski NE, Schatz AR, et al. (1995). Compton, identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. Biochem Pharmacol 50: 83-90.
    • (1995) Biochem Pharmacol , vol.50 , pp. 83-90
    • Mechoulam, R.1    Ben-Shabat, S.2    Hanus, L.3    Ligumsky, M.4    Kaminski, N.E.5    Schatz, A.R.6
  • 26
    • 56249108088 scopus 로고    scopus 로고
    • Tetrahydrolipstatin analogues as modulators of endocannabinoid 2-arachidonoylglycerol metabolism
    • Ortar G, Bisogno T, Ligresti A, Morera E, Nalli M, Di Marzo V, (2008). Tetrahydrolipstatin analogues as modulators of endocannabinoid 2-arachidonoylglycerol metabolism. J Med Chem 51: 6970-6979.
    • (2008) J Med Chem , vol.51 , pp. 6970-6979
    • Ortar, G.1    Bisogno, T.2    Ligresti, A.3    Morera, E.4    Nalli, M.5    Di Marzo, V.6
  • 27
    • 43949121784 scopus 로고    scopus 로고
    • Ligands that target cannabinoid receptors in the brain: From THC to anandamide and beyond
    • Pertwee RG, (2008). Ligands that target cannabinoid receptors in the brain: from THC to anandamide and beyond. Addict Biol 13: 147-159.
    • (2008) Addict Biol , vol.13 , pp. 147-159
    • Pertwee, R.G.1
  • 28
    • 0031902759 scopus 로고    scopus 로고
    • SR 141716, a CB1 cannabinoid receptor antagonist, selectively reduces sweet food intake in marmoset
    • Simiand J, Keane M, Keane PE, Soubrié P, (1998). SR 141716, a CB1 cannabinoid receptor antagonist, selectively reduces sweet food intake in marmoset. Behav Pharmacol 9: 179-181.
    • (1998) Behav Pharmacol , vol.9 , pp. 179-181
    • Simiand, J.1    Keane, M.2    Keane, P.E.3    Soubrié, P.4
  • 29
    • 80052273507 scopus 로고    scopus 로고
    • Distribution of diacylglycerol lipase alpha, an endocannabinoid synthesizing enzyme, in the rat forebrain
    • Suárez J, Ortíz O, Puente N, Bermúdez-Silva FJ, Blanco E, Fernández-Llebrez P, et al. (2011). Distribution of diacylglycerol lipase alpha, an endocannabinoid synthesizing enzyme, in the rat forebrain. Neuroscience 192: 112-131.
    • (2011) Neuroscience , vol.192 , pp. 112-131
    • Suárez, J.1    Ortíz, O.2    Puente, N.3    Bermúdez-Silva, F.J.4    Blanco, E.5    Fernández-Llebrez, P.6
  • 31
    • 79959653392 scopus 로고    scopus 로고
    • Rimonabant redux and strategies to improve the future outlook of CB1 receptor neutral-antagonist/inverse-agonist therapies
    • Ward SJ, Raffa RB, (2011). Rimonabant redux and strategies to improve the future outlook of CB1 receptor neutral-antagonist/inverse-agonist therapies. Obesity (Silver Spring) 19: 1325-1334.
    • (2011) Obesity (Silver Spring) , vol.19 , pp. 1325-1334
    • Ward, S.J.1    Raffa, R.B.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.